Home » Business News » 2013 » October » October 22, 2013

CellaVision awarded Best Optics and Photonics Company

October 22, 2013 - London

CellaVision is this year's winner of PhotonicSweden's industry award for its contribution to the laboratory medicine industry due to its technology strength within the field of Optics and Photonics and successful business development. The prize was handed today to CEO Yvonne Mårtensson at a ceremony at the conference on Optics and Photonics in Uppsala, Sweden.

Annually, renowned organization PhotonicSweden awards a prize for the best company in optics and photonics of the year, in terms of both business and technological advancement.

The jury's motivation: CellaVision is the world leader in digital microscopy used for hematology. Since it was founded in 1994, it has developed into an important player in the field of laboratory medicine and the company supplies its product to commercial laboratories and hospital laboratories all over the world. CellaVision is well on the way in establishing a global standard for digital microscopy. During recent years CellaVision has also proved that it can increase its turnover while keeping good profitability.

In 2012 CellaVision increased the number of sales partners and now has agreements with several major players in the market. Together with a broader product portfolio, including launch of two new products during the year, this gives CellaVision a stable base for continued profitable growth. CellaVision is a good example showing that Swedish biophotonics has a great potential.

"It is a great honor for us to receive this award, especially given that there is an amazing group of companies to choose from. We are proud and honored, and consider the price as significant for our visibility in the industry. It is a great tribute to our CellaVision team", said Yvonne Mårtensson, CEO of CellaVision AB.

For more information, please contact
Yvonne Mårtensson, CEO, CellaVision AB
Tel: +46708 33 77 82 | Email:

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading- edge expertise in image analysis, artificial intelligence and automated microscopy. In most countries sales are via global partners. Products are sold directly in the Nordic countries and via subsidiaries in the US, Canada and Japan. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at

About PhotonicSweden
PhotonicSweden is an economic association which was founded in 2011 in order to unify the community  of the Swedish optics and photonics,  including companies, R&D organizations, academia and competence centre in order to strengthen the field. PhotonicSweden enables a stronger collaboration of industry and science and is the voice towards the national and international community in optics and photonics.

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: CellaVision AB via Thomson Reuters ONE



Comment on this story